Thank you for your interest, but unfortunately, we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out your information using our Join a Study form, and a member of our team will contact you.
We’re Collecting Info on CIMZIA® When Taken in Pregnancy
MotherToBaby is currently enrolling participants into an observational study examining the use of CIMZIA® (certolizumab pegol) when taken during pregnancy to treat ankylosing spondylitis, Crohn’s disease, psoriasis, psoriatic arthritis, and/or rheumatoid arthritis. Our research is by observation only—we will not ask you to take or change any medications. If you join our CIMZIA® study, our team will simply collect some information about your pregnancy and your baby’s development for a period of time after birth. If you have taken CIMZIA® during your current pregnancy, you may qualify for this important study.
Find out more below!
Questions?
To connect with our research team, please contact us at
Phone | 877.311.8972
Email | mothertobaby@health.ucsd.edu
We’re open Monday – Thursday from 7am – 7pm and Friday 7am – 6pm Pacific, excluding public holidays.
You can also visit our Frequently Asked Questions to learn more about participating in our studies.
How Our Studies Work
Parent-To-Be Enrolls in Study
We Gather Info about the Pregnancy
Discoveries & Insights Gained
What’s Involved?
What is MotherToBaby Pregnancy Studies?
MotherToBaby Pregnancy Studies is a research program seeking to understand how certain medications, vaccines, or health conditions may affect pregnancy. Our research will help people who are pregnant and/or breastfeeding and health providers make informed treatment decisions. All of our studies are observational: we will never ask someone to take or change any aspect of their current health routine.
Who Leads MotherToBaby Pregnancy Studies?
Christina Chambers, PhD, MPH is the lead investigator for MotherToBaby Pregnancy Studies, which are coordinated by UC San Diego’s Center for Better Beginnings. She is a world‐renowned perinatal epidemiologist and a Professor of Pediatrics and Family and Preventive Medicine at the UC San Diego. Her interests are in the areas of birth defects and other pregnancy outcomes, with a special focus on exposures that can cause birth defects.
“Every person deserves to know if their health conditions or the medication they need to take could affect their baby during pregnancy. We are committed to bringing you better information for healthier outcomes.”
– Christina Chambers, PhD, MPH
Will you take the next step and help us learn more about the use of CIMZIA® during pregnancy?
